Previous close | 8.20 |
Open | 17.07 |
Bid | 13.80 |
Ask | 15.00 |
Strike | 600.00 |
Expiry date | 2023-03-17 |
Day's range | 13.00 - 20.50 |
Contract range | N/A |
Volume | |
Open interest | 549 |
On the call with me today is Marc Casper, our chairman, president, and chief executive officer; and Stephen Williamson, senior vice president, and chief financial officer. A copy of the press release of our fourth quarter and full year 2022 earnings is available in the Investors section of our website under the heading Financials.
Robust year-over-year growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments boost Thermo Fisher's (TMO) Q4 revenues.
Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.